FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
Yeztugo by Gilead Gets FDA OK, Promises Easier HIV Prevention
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)…
